SAB Biotherapeutics (SABSW) Q1 2025 Earnings

Jan 2Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.19
-0.97
-0.76
-0.54

Details

Expected EPS
-1.164
Actual EPS
-1.185
Surprise EPS
-0.02
Surprise Percent
-1.8%

Description

⁨SAB Biotherapeutics⁩ (⁦SABSW⁩) has reported earnings of ⁦-1.185⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts